Skip to main content

SpringWorks Therapeutics’ stock jumps after FDA approves first treatment for rare type of aggressive tumors

SpringWorks shares jumped early Tuesday after regulatory approval for tumor treatment
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.